claim: swissmedic starts rolling generation of a covid-19 vaccine
evidence_1: using the procedure, swissmedic can review data from ongoing clinical trials as soon as it is available.", "rolling submission enables swissmedic to build up a picture of the vaccines risk-benefit profile even before the pivotal clinical trials have been completed.")